2022
DOI: 10.1016/j.hsr.2022.100040
|View full text |Cite
|
Sign up to set email alerts
|

Insights into COVID-19 vaccines development: Translation from benchside to bedside

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 75 publications
0
1
0
Order By: Relevance
“…More than 3,810,000,000 people have received at least one dose of one of the COVID-19 vaccines, which equals approximately 49.7% of the world population. 2 However, constantly emerging SARS-CoV-2 variants are exhibiting heterogenous behaviour regarding immune invasion, transmissibility, and clinical manifestations. The Delta variant was the dominant strain until Omicron emerged in November of 2021.…”
Section: Introductionmentioning
confidence: 99%
“…More than 3,810,000,000 people have received at least one dose of one of the COVID-19 vaccines, which equals approximately 49.7% of the world population. 2 However, constantly emerging SARS-CoV-2 variants are exhibiting heterogenous behaviour regarding immune invasion, transmissibility, and clinical manifestations. The Delta variant was the dominant strain until Omicron emerged in November of 2021.…”
Section: Introductionmentioning
confidence: 99%